Melika Jameie

468 total citations
38 papers, 274 citations indexed

About

Melika Jameie is a scholar working on Neurology, Infectious Diseases and Psychiatry and Mental health. According to data from OpenAlex, Melika Jameie has authored 38 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 8 papers in Infectious Diseases and 7 papers in Psychiatry and Mental health. Recurrent topics in Melika Jameie's work include Long-Term Effects of COVID-19 (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Multiple Sclerosis Research Studies (5 papers). Melika Jameie is often cited by papers focused on Long-Term Effects of COVID-19 (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Multiple Sclerosis Research Studies (5 papers). Melika Jameie collaborates with scholars based in Iran, United States and Italy. Melika Jameie's co-authors include Nima Rezaei, Arash Heidari, Masoumeh Khalili, Mona Farhadi, Mehrdad Jahanshahi, Mehran Rahimlou, Saba Ilkhani, Shahin Akhondzadeh, Hossein Sanjari Moghaddam and Mohammad Hossein Harirchian and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Melika Jameie

30 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melika Jameie Iran 9 58 55 49 34 29 38 274
Koji Abe Japan 10 69 1.2× 72 1.3× 44 0.9× 8 0.2× 97 3.3× 29 271
Zhe Yu China 13 120 2.1× 84 1.5× 30 0.6× 17 0.5× 72 2.5× 41 511
Abbas Jarrahi United States 8 122 2.1× 167 3.0× 45 0.9× 19 0.6× 23 0.8× 11 414
Fausto Rojas-Durán Mexico 9 85 1.5× 61 1.1× 20 0.4× 12 0.4× 25 0.9× 42 304
Arman Fesharaki‐Zadeh United States 8 111 1.9× 155 2.8× 52 1.1× 26 0.8× 53 1.8× 16 309
Sam Mathai New Zealand 16 109 1.9× 43 0.8× 64 1.3× 42 1.2× 40 1.4× 22 510
Hiroki Tateiwa Japan 12 50 0.9× 19 0.3× 69 1.4× 102 3.0× 48 1.7× 29 322
Delia Tulbă Romania 9 148 2.6× 118 2.1× 49 1.0× 14 0.4× 100 3.4× 18 360
Joseph M. Hall United States 10 35 0.6× 116 2.1× 69 1.4× 35 1.0× 36 1.2× 10 457
François Chavant France 10 78 1.3× 28 0.5× 43 0.9× 10 0.3× 68 2.3× 13 309

Countries citing papers authored by Melika Jameie

Since Specialization
Citations

This map shows the geographic impact of Melika Jameie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melika Jameie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melika Jameie more than expected).

Fields of papers citing papers by Melika Jameie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melika Jameie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melika Jameie. The network helps show where Melika Jameie may publish in the future.

Co-authorship network of co-authors of Melika Jameie

This figure shows the co-authorship network connecting the top 25 collaborators of Melika Jameie. A scholar is included among the top collaborators of Melika Jameie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melika Jameie. Melika Jameie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paybast, Sepideh, et al.. (2026). Extended interval dosing of off-label rituximab in multiple sclerosis: A real-world retrospective analysis of clinical efficacy and safety. Multiple Sclerosis and Related Disorders. 107. 106998–106998.
2.
3.
4.
Jameie, Melika, Hamidreza Soleimani, Arash Jalali, et al.. (2024). Impact of Multiarterial Revascularization on Long-term Major Adverse Cardiovascular Events After Coronary Bypass in 23,798 Patients. The Annals of Thoracic Surgery. 118(4). 863–872. 2 indexed citations
5.
Jameie, Melika, et al.. (2024). The hidden link: How oral and respiratory microbiomes affect multiple sclerosis. Multiple Sclerosis and Related Disorders. 88. 105742–105742. 2 indexed citations
6.
Jameie, Melika, Mehdi Azizmohammad Looha, Giulia Cattarinussi, et al.. (2024). Machine learning applied to the prediction of relapse, hospitalization, and suicide in bipolar disorder using neuroimaging and clinical data: A systematic review. Journal of Affective Disorders. 361. 778–797. 11 indexed citations
7.
8.
Jameie, Melika, et al.. (2024). Association of New-Onset Seizures With SARS-CoV-2 Vaccines. JAMA Neurology. 81(6). 611–611. 2 indexed citations
9.
10.
11.
Jameie, Melika, et al.. (2023). Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy. JAMA Otolaryngology–Head & Neck Surgery. 149(6). 493–493. 20 indexed citations
12.
Jameie, Melika, et al.. (2023). Association of seizure with COVID‐19 vaccines in persons with epilepsy: A systematic review and meta‐analysis. Journal of Medical Virology. 95(9). e29118–e29118. 8 indexed citations
13.
Khanmohammadi, Shaghayegh, et al.. (2023). Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review. Multiple Sclerosis and Related Disorders. 82. 105415–105415. 3 indexed citations
14.
Jameie, Melika, et al.. (2023). Two ischemic stroke events within 48 h: a case report of an unusual presentation of thrombotic thrombocytopenic purpura. BMC Neurology. 23(1). 47–47. 1 indexed citations
15.
16.
Jameie, Melika, et al.. (2022). The relationship between cardiological parameters and PCR in patients with coronavirus infection: A cross-sectional study. Medicine. 101(50). e31935–e31935. 1 indexed citations
17.
Jameie, Melika, et al.. (2022). Sleep microstructure and clinical characteristics of patients with restless legs syndrome. Journal of Clinical Sleep Medicine. 18(11). 2653–2661. 4 indexed citations
18.
Jameie, Melika, et al.. (2021). COVID-19 and acute kidney injury presentation; stages and prognosis. SHILAP Revista de lepidopterología. 6(1). e15–e15. 1 indexed citations
19.
Jahanshahi, Mehrdad, et al.. (2020). 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels. Journal of Basic and Clinical Physiology and Pharmacology. 32(2). 11–17. 26 indexed citations
20.
Farhadi, Mona, et al.. (2016). Effects of Exogenous Estrogen Treatment on Hippocampal Neurogenesis of Diabetic Ovariectomized Rats. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Abe Breakdown of academic impact, for papers by Zhe Yu Breakdown of academic impact, for papers by Abbas Jarrahi Breakdown of academic impact, for papers by Fausto Rojas-Durán Breakdown of academic impact, for papers by Arman Fesharaki‐Zadeh Breakdown of academic impact, for papers by Sam Mathai Breakdown of academic impact, for papers by Hiroki Tateiwa Breakdown of academic impact, for papers by Delia Tulbă Breakdown of academic impact, for papers by Joseph M. Hall Breakdown of academic impact, for papers by François Chavant
Rankless by CCL
2026